Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Crawley

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Plos One|May 3, 2019
Csf1r or Mer inhibition delays liver regeneration via suppression of Kupffer cellsJuan A Santamaria-Barria, Shan Zeng, Jonathan B Greer, et al.
Royal Society Open Science|April 11, 2024
Asian elephant calf physiology and mahout perspectives during taming in MyanmarJennie A H Crawley, Hnin Nandar, Htet T Zaw, et al.
Plos One|May 10, 2017
Genome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulationEric C Sorenson, Raya Khanin, Zubin M Bamboat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2016
PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal TumorsAdrian M Seifert, Shan Zeng, Jennifer Q Zhang, et al.
Cancer Research|April 4, 2015
Pharmacological Inhibition of KIT Activates MET Signaling in Gastrointestinal Stromal TumorsNoah A Cohen, Shan Zeng, Adrian M Seifert, et al.
The Journal of Experimental Medicine|December 11, 2013
KIT oncogene inhibition drives intratumoral macrophage M2 polarizationMichael J Cavnar, Shan Zeng, Teresa S Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2014
Increased KIT inhibition enhances therapeutic efficacy in gastrointestinal stromal tumorTeresa S Kim, Michael J Cavnar, Noah A Cohen, et al.
Molecular Cancer Therapeutics|June 15, 2017
Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal TumorShan Zeng, Adrian M Seifert, Jennifer Q Zhang, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Plos One|May 3, 2019
Csf1r or Mer inhibition delays liver regeneration via suppression of Kupffer cellsJuan A Santamaria-Barria, Shan Zeng, Jonathan B Greer, et al.
Royal Society Open Science|April 11, 2024
Asian elephant calf physiology and mahout perspectives during taming in MyanmarJennie A H Crawley, Hnin Nandar, Htet T Zaw, et al.
Plos One|May 10, 2017
Genome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulationEric C Sorenson, Raya Khanin, Zubin M Bamboat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2016
PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal TumorsAdrian M Seifert, Shan Zeng, Jennifer Q Zhang, et al.
Cancer Research|April 4, 2015
Pharmacological Inhibition of KIT Activates MET Signaling in Gastrointestinal Stromal TumorsNoah A Cohen, Shan Zeng, Adrian M Seifert, et al.
The Journal of Experimental Medicine|December 11, 2013
KIT oncogene inhibition drives intratumoral macrophage M2 polarizationMichael J Cavnar, Shan Zeng, Teresa S Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2014
Increased KIT inhibition enhances therapeutic efficacy in gastrointestinal stromal tumorTeresa S Kim, Michael J Cavnar, Noah A Cohen, et al.
Molecular Cancer Therapeutics|June 15, 2017
Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal TumorShan Zeng, Adrian M Seifert, Jennifer Q Zhang, et al.
Pageof 3